Indication
CADASIL
3 clinical trials
4 products
Clinical trial
A Randomized, Double-blind, Single-centre, Two-period Cross-over, Placebo-controlled Trial on Safety and Efficacy in Patients With Genetically Proven CADASILStatus: Recruiting, Estimated PCD: 2026-03-31
Product
CerebrolysinProduct
0.9% NaClClinical trial
A Multicenter, Single-arm, Clinical Trial of Adrenomedullin for Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyStatus: Completed, Estimated PCD: 2023-01-23
Product
AdrenomedullinClinical trial
Retinal Vasoreactivity is a Marker for Cerebral Small Vessel Disease ProgressionStatus: Recruiting, Estimated PCD: 2026-06-01
Product
Cilostazol